$STOK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Stoke Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Stoke Therapeutics, Inc.. Get notifications about new insider transactions in Stoke Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2020 | STOK | Stoke Therapeutics ... | Walker Robin A. | Chief Legal Officer ... | Option Exercise | A | 20.25 | 60,000 | 1,215,000 | 60,000 | |
| Mar 26 2020 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | A | 20.25 | 60,000 | 1,215,000 | 60,000 | |
| Mar 26 2020 | STOK | Stoke Therapeutics ... | Ticho Barry | Chief Medical Offic ... | Option Exercise | A | 20.25 | 60,000 | 1,215,000 | 60,000 | |
| Mar 26 2020 | STOK | Stoke Therapeutics ... | Liau Gene | EVP Research & Prec ... | Option Exercise | A | 20.25 | 42,000 | 850,500 | 42,000 | |
| Mar 26 2020 | STOK | Stoke Therapeutics ... | Kaye Edward M. MD | CEO | Option Exercise | A | 20.25 | 197,000 | 3,989,250 | 197,000 | |
| Mar 26 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | A | 20.25 | 60,000 | 1,215,000 | 60,000 | |
| Mar 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 2.19 | 42,779 | 93,686 | 230,818 | |
| Mar 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Option Exercise | M | 0.40 | 6,324 | 2,530 | 146,000 | |
| Mar 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 26.37 | 15,995 | 421,852 | 0 | 16 K to 0 (-100.00 %) |
| Mar 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Sell | S | 25.66 | 33,148 | 850,697 | 15,995 | 49.1 K to 16 K (-67.45 %) |
| Mar 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 2.19 | 42,779 | 93,686 | 49,103 | 6.3 K to 49.1 K (+676.45 %) |
| Mar 04 2020 | STOK | Stoke Therapeutics ... | Nash Huw M. | COO & CBO | Buy | M | 0.40 | 6,324 | 2,530 | 6,324 | 0 to 6.3 K |
| Nov 18 2019 | STOK | Stoke Therapeutics ... | Walker Robin A. | Chief Legal Officer | Option Exercise | A | 23.32 | 84,800 | 1,977,536 | 84,800 | |
| Nov 12 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Sell | S | 28.70 | 16,434 | 471,631 | 3,544,248 | 3.6 M to 3.5 M (-0.46 %) |
| Nov 06 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 29.24 | 104,873 | 3,066,843 | 3,560,682 | 3.5 M to 3.6 M (+3.03 %) |
| Nov 01 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 28.61 | 8,598 | 245,950 | 3,455,809 | 3.4 M to 3.5 M (+0.25 %) |
| Nov 01 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 28.15 | 18,747 | 527,659 | 3,447,211 | 3.4 M to 3.4 M (+0.55 %) |
| Nov 01 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 28.79 | 41,438 | 1,193,004 | 3,428,464 | 3.4 M to 3.4 M (+1.22 %) |
| Oct 02 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 21.96 | 31,560 | 693,029 | 3,387,026 | 3.4 M to 3.4 M (+0.94 %) |
| Sep 12 2019 | STOK | Stoke Therapeutics ... | Hall Samuel W. | Director | Option Exercise | A | 28.80 | 29,555 | 851,184 | 29,555 | |
| Sep 12 2019 | STOK | Stoke Therapeutics ... | Burstein Jennifer | Director | Option Exercise | A | 28.80 | 29,555 | 851,184 | 29,555 | |
| Sep 12 2019 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 28.80 | 14,777 | 425,578 | 14,777 | |
| Sep 12 2019 | STOK | Stoke Therapeutics ... | LEVIN ARTHUR A | Director | Option Exercise | A | 28.80 | 14,777 | 425,578 | 14,777 | |
| Sep 12 2019 | STOK | Stoke Therapeutics ... | Krainer Adrian R. | Director | Option Exercise | A | 28.80 | 14,777 | 425,578 | 14,777 | |
| Sep 12 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | A | 28.80 | 29,555 | 851,184 | 29,555 | |
| Jun 24 2019 | STOK | Stoke Therapeutics ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 671,808 | 0 | 0 | |
| Jun 24 2019 | STOK | Stoke Therapeutics ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 671,808 | 0 | 671,808 | 0 to 671.8 K |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Apple Tree Partners IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,799,910 | 0 | 0 | |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Apple Tree Partners IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,617,746 | 0 | 0 | |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Apple Tree Partners IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,980,168 | 0 | 0 | |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Apple Tree Partners IV, L.P. | 10% Owner | Buy | P | 18.00 | 1,388,889 | 25,000,002 | 16,786,713 | 15.4 M to 16.8 M (+9.02 %) |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Apple Tree Partners IV, L.P. | 10% Owner | Buy | C | 0.00 | 2,799,910 | 0 | 15,397,824 | 12.6 M to 15.4 M (+22.23 %) |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Apple Tree Partners IV, L.P. | 10% Owner | Buy | C | 0.00 | 7,617,746 | 0 | 12,597,914 | 5 M to 12.6 M (+152.96 %) |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Apple Tree Partners IV, L.P. | 10% Owner | Buy | C | 0.00 | 4,980,168 | 0 | 4,980,168 | 0 to 5 M |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 2,799,910 | 0 | 0 | |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 7,617,746 | 0 | 0 | |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 4,980,168 | 0 | 0 | |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Buy | P | 18.00 | 1,388,889 | 25,000,002 | 16,786,713 | 15.4 M to 16.8 M (+9.02 %) |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Buy | C | 0.00 | 2,799,910 | 0 | 15,397,824 | 12.6 M to 15.4 M (+22.23 %) |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Buy | C | 0.00 | 7,617,746 | 0 | 12,597,914 | 5 M to 12.6 M (+152.96 %) |
| Jun 21 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Buy | C | 0.00 | 4,980,168 | 0 | 4,980,168 | 0 to 5 M |
| Jun 20 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Option Exercise | C | 0.00 | 2,799,910 | 0 | 0 | |
| Jun 20 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 18.00 | 555,556 | 10,000,008 | 3,355,466 | 2.8 M to 3.4 M (+19.84 %) |
| Jun 20 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | C | 0.00 | 2,799,910 | 0 | 2,799,910 | 0 to 2.8 M |
| Jun 20 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Option Exercise | C | 0.00 | 2,799,910 | 0 | 0 | |
| Jun 20 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 18.00 | 555,556 | 10,000,008 | 3,355,466 | 2.8 M to 3.4 M (+19.84 %) |
| Jun 20 2019 | STOK | Stoke Therapeutics ... | RTW INVESTMENTS, LP | 10% Owner | Buy | C | 0.00 | 2,799,910 | 0 | 2,799,910 | 0 to 2.8 M |